AtriCure, Inc. Advertising Revenue Cost (Deprecated 2018-01-31)
AtriCure, Inc. (ATRC) reported Advertising Revenue Cost (Deprecated 2018-01-31) of $900.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingRevenueCost · last filed 2018-02-28
- AtriCure, Inc. advertising revenue cost (deprecated 2018-01-31) for fiscal 2017 was $900.00K, a 44.00% increase from fiscal 2016.
- AtriCure, Inc. advertising revenue cost (deprecated 2018-01-31) for fiscal 2016 was $625.00K, a 31.30% increase from fiscal 2015.
- AtriCure, Inc. advertising revenue cost (deprecated 2018-01-31) for fiscal 2015 was $476.00K, a 10.02% decline from fiscal 2014.
- AtriCure, Inc. advertising revenue cost (deprecated 2018-01-31) for fiscal 2014 was $529.00K.
| Period end | Advertising Revenue Cost (Deprecated 2018-01-31) 12 month |
|---|---|
| 2017-12-31 | $900.00K 10-K · filed 2018-02-28 |
| 2016-12-31 | $625.00K 10-K · filed 2018-02-28 |
| 2015-12-31 | $476.00K 10-K · filed 2018-02-28 |
| 2014-12-31 | $529.00K 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |